Literature DB >> 11442588

Perineural invasion of cutaneous malignancies.

A M Feasel1, T J Brown, M A Bogle, J A Tschen, B R Nelson.   

Abstract

BACKGROUND: Perineural invasion is an important mode of tumor spread and is associated with increased aggressiveness and a propensity for recurrence among cutaneous malignancies.
OBJECTIVE: To review the pathogenesis, diagnosis, and treatment of cutaneous tumors exhibiting perineural invasion.
METHODS: This article is based on a review of the medical literature concerning tumors with perineural involvement.
RESULTS: This article describes the clinical signs and histologic features of cutaneous malignancies exhibiting perineural involvement.
CONCLUSION: Appropriate patient care mandates consideration of perineural invasion in the evaluation of cutaneous tumors. As the majority of patients present without symptoms of neural involvement, physicians must be vigilant in the search for this type of tumor spread.

Entities:  

Mesh:

Year:  2001        PMID: 11442588     DOI: 10.1046/j.1524-4725.2001.00330.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  17 in total

1.  Periocular keratoacanthoma: can we always rely on the clinical diagnosis?

Authors:  I Leibovitch; S C Huilgol; C L James; J D Hsuan; G Davis; D Selva
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

2.  Predicting the risk of non-organ-confined prostate cancer when perineural invasion is found on biopsy.

Authors:  Michael A Gorin; Heather J Chalfin; Jonathan I Epstein; Zhaoyong Feng; Alan W Partin; Bruce J Trock
Journal:  Urology       Date:  2014-03-19       Impact factor: 2.649

3.  A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics.

Authors:  Sharifeh Farasat; Siegrid S Yu; Victor A Neel; Kishwer S Nehal; Thomas Lardaro; Martin C Mihm; David R Byrd; Charles M Balch; Joseph A Califano; Alice Y Chuang; William H Sharfman; Jatin P Shah; Paul Nghiem; Clark C Otley; Anthony P Tufaro; Timothy M Johnson; Arthur J Sober; Nanette J Liégeois
Journal:  J Am Acad Dermatol       Date:  2011-01-20       Impact factor: 11.527

4.  Cutaneous adenoid cystic carcinoma with perineural invasion treated by mohs micrographic surgery-a case report with literature review.

Authors:  Yaohui G Xu; Molly Hinshaw; B Jack Longley; Humza Ilyas; Stephen N Snow
Journal:  J Oncol       Date:  2010-04-07       Impact factor: 4.375

Review 5.  Hide-and-seek: Neurotropic squamous cell carcinoma of the periorbital region - a series of five cases and review of the literature.

Authors:  Evi M Morandi; Tina Rauchenwald; Petra Puelzl; Bernhard W Zelger; Bettina G Zelger; Benjamin Henninger; Gerhard Pierer; Dolores Wolfram
Journal:  J Dtsch Dermatol Ges       Date:  2021-11       Impact factor: 5.231

6.  Dual S-100-AE1/3 Immunohistochemistry to Detect Perineural Invasion in Nonmelanoma Skin Cancers.

Authors:  Alma C Berlingeri-Ramos; Claire J Detweiler; Richard F Wagner; Brent C Kelly
Journal:  J Skin Cancer       Date:  2015-01-18

Review 7.  Review of Perineural Invasion in Keratinocyte Carcinomas.

Authors:  Albert E Zhou; Karl M Hoegler; Amor Khachemoune
Journal:  Am J Clin Dermatol       Date:  2021-06-08       Impact factor: 7.403

8.  Cutaneous adenoid cystic carcinoma of lower eyelid: Case report of a rare malignant entity.

Authors:  Salissou Iro; Mohamed Raiteb; Amina Maadane; Sanaa Elmrini; Faiçal Slimani
Journal:  Ann Med Surg (Lond)       Date:  2021-06-08

9.  Passively Scattered Proton Therapy for Nonmelanoma Skin Cancer with Clinical Perineural Invasion.

Authors:  Curtis M Bryant; Roi Dagan; Adam L Holtzman; Rui Fernandes; Anthony Bunnell; William M Mendenhall
Journal:  Int J Part Ther       Date:  2021-06-25

10.  Primary cutaneous adenoid carcinoma of the scalp.

Authors:  Meike Keck; Klaus Ueberreiter; Ursula Tanzella; Dietrich Doll; Björn Dirk Krapohl
Journal:  GMS Interdiscip Plast Reconstr Surg DGPW       Date:  2012-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.